DiscoveryBioMed, Inc. (DBM) is a life sciences and biotechnology company focused on integrating biologically- and disease-relevant human cell cultures and lines into all relevant steps in the Drug Discovery Critical Path. DBM specializes in multiplexed bioassays of targets and phenotypes using both mono- and multi-culture designs for primary Drug Discovery, as well as, hit-to-lead validation of existing hit-to-lead assets. Complementing its Drug Discovery efforts, DBM also specializes in custom cell culture and engineering and implementation of such cells at any and all inflections points within the Critical Path. It is DBM’s belief that our approach to Drug Discovery and Development serves as a complement to the more traditional approach within the BioPharmaceutical Indstury to improve the viability of hit, validated hit-to-lead and lead clinical candidate drugs.
View Top Employees from DiscoveryBioMed, Inc.Website | http://www.discoverybiomed.com |
Revenue | $1 million |
Employees | 7 (3 on RocketReach) |
Founded | 2007 |
Address | 400 Riverhills Business Park Suite 435, Birmingham, Alabama 35242, US |
Phone | (205) 918-8138 |
Fax | (205) 351-4120 |
Technologies |
JavaScript,
HTML,
PHP
+15 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Life Science, Medical Device, Health Care |
Web Rank | 35 Million |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular DiscoveryBioMed, Inc. employee's phone or email?
The DiscoveryBioMed, Inc. annual revenue was $1 million in 2024.
Erik Schwiebert is the Owner of DiscoveryBioMed, Inc..
3 people are employed at DiscoveryBioMed, Inc..
DiscoveryBioMed, Inc. is based in Birmingham, Alabama.
The NAICS codes for DiscoveryBioMed, Inc. are [54171, 54, 541714, 541, 5417].
The SIC codes for DiscoveryBioMed, Inc. are [873, 87].